Anteris Technologies Global Corp AVR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $8.45
- Day Range
- $8.21–8.63
- 52-Week Range
- $2.98–11.06
- Bid/Ask
- $8.09 / $8.85
- Shares Outstanding
- 97.34M
- Market Cap
- $800.15M
- Volume/Avg
- 717,452 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 163.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 174
- Website
- https://www.anteristech.com
Valuation
|
Metric
|
AVR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.95 |
Price/Sales | 168.50 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AVR
|
|---|---|
Quick Ratio | 20.66 |
Current Ratio | 20.93 |
Interest Coverage | −1,288.31 |
Quick Ratio
AVR
Profitability
|
Metric
|
AVR
|
|---|---|
Return on Assets (Normalized) | −101.59% |
Return on Equity (Normalized) | −126.50% |
Return on Invested Capital (Normalized) | −122.95% |
Return on Assets
AVR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|Ms$&#ht | LOCK|%^?@> | $177B | |||
| Stryker Corp
SYK
| LOCK|#vm>jq@Z | LOCK|KF | $122B | |||
| Medtronic PLC
MDT
| LOCK|&RRlR> | LOCK|#drK | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|%WZ%FR& | LOCK|R^f# | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|vfs<>>M | LOCK|fPB< | $49B | |||
| DexCom Inc
DXCM
| LOCK|thX#%fD | LOCK|>Vq$ | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|WbV$sJ | LOCK|N&n | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|@t! | LOCK|k>D | $26B | |||
| Steris PLC
STE
| LOCK|b$<#fK$ | LOCK|B%T#B | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|wd<>^^v | LOCK|&Gn | $17B |
United States